Krishana Phoschem manufactures phosphatic fertilizers, specifically NPK, DAP, and SSP, operating with backward integration into rock phosphate beneficiation, sulfuric acid, and phosphoric acid. The company also runs a lower-margin trading business importing fertilizer variants to supplement its manufacturing shelf. Money is primarily made in the manufacturing segment, which generated approximately Rs.1,900 crore in FY26 revenue and commands EBITDA margins of 14-16%, significantly higher than the 7-8% margins seen in its trading arm. The competitive structure is concentrated, as domestic rock phosphate beneficiation is limited to only three players in India due to constrained access to limited domestic reserves. This limited field and the company's integrated asset base support manufacturing EBITDA per ton of roughly Rs.6,000 for NPK and Rs.1,500-1,600 for SSP, placing its profitability firmly in the good-to-exceptional range for a converter business.
The economics of this business persist through cycles due to specific, underappreciated barriers rather than broad commodity scale. The primary moat is the company's backward integration into sulphuric and phosphoric acid, which provides a tangible cost cushion against global raw material volatility. Furthermore, rock phosphate beneficiation is structurally restricted because domestic reserves are limited and access is tightly controlled, making this asset base non-replicable for new entrants. The business also benefits from high switching costs and mission-critical demand dynamics, as domestic phosphatic fertilizer supply is insufficient and relies on imports for roughly 40-50% of consumption. This insulates domestic manufacturers from demand softening, as imports absorb market shocks first. The company's ability to pass 25-30% of input cost increases to customers through subsidy support and MRP revisions further stabilizes its converter economics through pricing cycles.
The inflection point driving the thesis is the recent commissioning of a 165,000 MTPA NPK/DAP expansion at Meghnagar, increasing total NPK/DAP capacity by 50% to 495,000 MTPA and bringing total phosphatic capacity to 615,000 MTPA. In Q1 FY27, the new plant operated at 43% utilization, generating manufacturing revenue of Rs.359 crore. Over the next 18-24 months, management targets ramping this utilization to 80% or higher, driving a 30-35% turnover growth for FY27 and targeting a quarterly run-rate exceeding Rs.500 crore. By FY29, the business is expected to look materially different, with the expanded asset base generating revenue potential exceeding Rs.3,000 crore at full utilization. Concurrently, a 10-year agreement for 70,000 MTPA of Green Ammonia is slated to commence in FY29, securing the lowest cost raw material sourcing in the domestic industry and further deepening backward integration.
Management's walk-talk demonstrates high consistency in executing this capacity-led growth strategy. In October 2025, the Meghnagar expansion was guided for a March 2026 commissioning at a capex of Rs.142 crore, funded via a Rs.75 crore term loan and internal accruals. By January 2026, machinery orders were placed and civil work was nearly complete. The plant successfully commenced commercial production in April 2026, matching the timeline promised across three consecutive concalls. Guidance has been consistently maintained or raised, with FY26 revenue exceeding the initial Rs.1,500 crore conservative target to reach roughly Rs.1,900 crore in manufacturing alone. Capital allocation remains disciplined, with no additional capex planned beyond the current expansion and no equity dilution executed. The only friction point has been blended margin compression due to a higher mix of low-margin trading business, which management explicitly flagged as a temporary mix issue rather than a manufacturing shortfall.
Earnings visibility is anchored by the concrete capacity ramp-up path and a targeted manufacturing EBITDA margin of 16-17% for the remaining quarters of FY27. The quantified path implies FY27 revenue of Rs.2,900-3,000 crore, supported by manufacturing EBITDA per ton of Rs.6,000 for NPK and Rs.1,500-1,600 for SSP. For this trajectory to hold, the company must achieve steady utilization ramp-up without prolonged production halts from grade switching or raw material logistics issues. The single most important falsifier is global raw material cost inflation, particularly for sulphur and ammonia, which surged to nearly Rs.1 lakh per tonne in June 2026. If input costs spike faster than the 25-30% pass-through mechanism allows, or if subsidy receivables stretch beyond the 100-day cycle and strain working capital, the operating leverage thesis breaks. Resolving the tension between declining sequential PAT margins from 11% to 8.9% and improving manufacturing EBITDA, the margin dip is purely operational, driven by depreciation and finance costs from the newly commissioned plant, which operating leverage will offset as utilization scales.
companyname: Krishana Phoschem Limited ticker: KRISHANA sector: Phosphatic Fertilizers / Chemicals Krishana Phoschem is an integrated phosphatic fertiliser manufacturer within the Ostwal Group. It operates a single manufacturing complex at Meghnagar, Madhya Pradesh, producing Single Super Phosphate (SSP), NPK/DAP complex fertilisers, sulphuric acid, phosphoric acid, and beneficiated rock phosphate (BRP). It sells under the 'Annadata' and 'Bharat' brands across 12 states in Central, Northern, an...
Read the full report →capex, margin expansion
FY26 Revenue guidance: ₹1,500+ crores; new 1,65,000 MTPA NPK/DAP plant to add ₹1,000 crores revenue at 60% utilisation in FY27
Guidance maintainedconsistent
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Krishana Phoschem Limited and 4,900+ companies.
5-day free pass. No card required.